Cradle vs Ordaos

<p>Cradle is an AI-powered protein engineering platform designed for biotech and pharmaceutical R&amp;D teams. It helps you generate optimized protein candidates quickly, co-optimize various complex protein properties, and track experimental results all within one secure software. By leveraging your own laboratory data, Cradle continuously improves its models to produce highly efficient protein designs suitable for therapeutics, enzymes, vaccines, and more. It enables you to explore multiple design strategies and reduce development timelines significantly.</p> <p>With Cradle, you gain a streamlined workflow from data import and quality analysis to candidate generation and detailed report review. It supports privacy and data security with bank-grade protections and SOC 2 compliance, ensuring your proprietary data and intellectual property remain yours. The software also provides dedicated scientific support, zero-maintenance AI infrastructure, and integration options like single sign-on. This platform suits teams aiming to shorten product development cycles and bring innovative biosolutions to market faster via AI-driven protein design.</p>

<p>Ordaōs is an AI-driven platform that designs de novo mini-proteins and single domain antibodies to support drug hunters in creating novel, effective therapies. It leverages its proprietary Design Engine, which applies generative AI, meta-learning, and reinforcement learning to generate and optimize miniPRO™ proteins meeting specific therapeutic targets.</p> <p>With Ordaōs, you can achieve faster drug candidate development cycles and higher confidence in investigational new drugs. Its platform offers scalability, repeatability, and configurability in protein design, helping pharmaceutical and biotech partners reduce patient suffering with safer, more effective treatments developed in weeks rather than months or years.</p>